Canada Health Canada provides guidance for clinical trials on psychedelics The notice to stakeholders outlined risk management and consent expectations for the study of psychoactive drugs Rowan DunneDecember 5, 2022
Canada Alberta pioneers psychedelic therapy regulations in Canada New amendment to the Mental Health Services Protection Regulation has been initiated to effectively safeguard patients Rowan DunneOctober 6, 2022
Canada PsyCan pushes federal policy-makers to lift restrictions on psychedelics Non-profit says Canada needs to make room for healthcare innovation with respect to psychedelic therapies Rowan DunneSeptember 21, 2022
Psychedelics Nirvana Life Sciences boasts new patent for innovative psychedelic compound Company isolates 4-PO-Psilocin into biologically active salt with 99% purity ratio Rowan DunneJune 23, 2022
Business Numinus completes Novamind acquisition, upgrades leadership team Novamind's clinics in Utah and Arizona will continue to operate as their current brand until later this year Natalia Buendia CalvilloJune 14, 2022
Business Numinus to enter US psychedelics market via $26.2M Novamind acquisition The transaction is expected to close around June Natalia Buendia CalvilloApril 12, 2022
Business Numinus gets new biosecurity licence to expand psilocybin research CEO Payton Nyquvest says the authorization moves his firm closer to developing medicines at scale to support psychedelic-assisted therapy Nick LabaMarch 14, 2022
News Psilocybin therapy for major depression can relieve symptoms for a year: study The long-term benefits contrast with the more temporary effects of conventional antidepressants Natalia Buendia CalvilloFebruary 18, 2022
Business Numinus ups revenue 61% thanks to psychedelic-focused therapy programs Expenses were down 71% but the firm still reported a $5.4-million loss Natalia Buendia CalvilloJanuary 21, 2022
Psychedelics Palliative care providers see psychedelic-assisted therapy as treatment option for existential distress: study Currently treatments are largely insufficient, so care providers encourage more research despite stigma Natalia Buendia CalvilloDecember 30, 2021